India's First Indigenous Hepatitis A Vaccine: Havisure
Indian Immunologicals launches Havisure, India's first indigenously developed Hepatitis A vaccine, offering protection against the viral infection.

New Delhi, Jan 19 (PTI) Indian Immunologicals on Friday said it has launched the country's first indigenously developed Hepatitis A vaccine.
The vaccine -- Havisure -- represents a significant step forward in the country's fight against Hepatitis A, the company, which is a wholly-owned subsidiary of the National Dairy Development Board (NDDB), said in a statement.
Hepatitis A is a viral infection primarily spread through the fecal-oral route, meaning that it is transmitted through the ingestion of contaminated food or water.
"Currently Hepatitis A vaccines are imported into the country...Havisure has undergone extensive clinical trials in eight centres and has proven to be safe and efficacious," Indian Immunologicals Ltd (IIL) Managing Director K Anand Kumar said.
The vaccine is comparable to the world's leading vaccine sold by multinational companies, he added.
Havisure is a two-dose vaccine wherein the first dose is administered at above 12 months of age and the second dose is given at least after 6 months of the first dose.
The vaccine -- Havisure -- represents a significant step forward in the country's fight against Hepatitis A, the company, which is a wholly-owned subsidiary of the National Dairy Development Board (NDDB), said in a statement.
Hepatitis A is a viral infection primarily spread through the fecal-oral route, meaning that it is transmitted through the ingestion of contaminated food or water.
"Currently Hepatitis A vaccines are imported into the country...Havisure has undergone extensive clinical trials in eight centres and has proven to be safe and efficacious," Indian Immunologicals Ltd (IIL) Managing Director K Anand Kumar said.
The vaccine is comparable to the world's leading vaccine sold by multinational companies, he added.
Havisure is a two-dose vaccine wherein the first dose is administered at above 12 months of age and the second dose is given at least after 6 months of the first dose.
You May Like To Read
TODAY'S MOST TRADED COMPANIES
- Company Name
- Price
- Volume
- Vodafone-Idea-L
- 11.25 (+ 4.85)
- 124593459
- Mangalam-Industrial
- 0.90 (+ 4.65)
- 43018654
- Welcure-Drugs-and
- 0.50 (+ 4.17)
- 39983710
- Alstone-Textiles
- 0.29 ( -3.33)
- 27516634
- Murae-Organisor
- 0.27 (+ 3.85)
- 26520405






